Glymphatic imaging and serum glial biomarkers in children with obstructive sleep apnea

Birce Sunman1, Ömer Faruk İpek1, Ekim Gümeler2

  • 1Hacettepe University Faculty of Medicine, Department of Pediatric Pulmonology, Ankara, Türkiye.

Sleep Medicine
|April 25, 2026
PubMed

Insights

Obstructive sleep apnea (OSA) in obese children is linked to impaired glymphatic system function. This is shown by a lower diffusion tensor imaging-along the perivascular space (DTI-ALPS) index and higher glial fibrillary acidic protein (GFAP) levels.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Sleep Medicine

Background:

  • The glymphatic system clears waste from the brain, primarily during sleep.
  • Obstructive sleep apnea (OSA) may disrupt glymphatic function.
  • Biomarkers like GFAP and S100B may indicate brain injury or inflammation.

Purpose of the Study:

  • To assess glymphatic system function in obese children with OSA.
  • To correlate glymphatic function with serum biomarkers (GFAP, S100B).
  • To utilize the DTI-ALPS index for glymphatic evaluation.

Main Methods:

  • Enrolled obese children undergoing polysomnography (PSG) to diagnose OSA.
  • Included age- and sex-matched healthy non-obese children as controls.
  • Acquired brain MRI for DTI-ALPS index calculation and blood samples for GFAP/S100B levels.

Main Results:

  • Obese children with OSA showed a significantly lower DTI-ALPS index compared to obese non-OSA and healthy controls.
  • Serum GFAP levels were significantly elevated in the obese OSA group.
  • No significant difference in S100B levels was observed between groups.

Conclusions:

  • Obese children with OSA exhibit impaired glymphatic function.
  • Reduced DTI-ALPS index and elevated GFAP suggest glial activation and dysfunction.
  • Further longitudinal research is needed to establish causality.
Abstract

Related Concept Videos